StonvexLoading…
StonvexStonvexStonvexCore line items from CRIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.44M | $10.91M | $10.02M | $10.16M |
Operating Income | $-5.71M | $-44.54M | $-48.33M | $-53.02M |
Net Income | $-7.58M | $-43.39M | $-47.41M | $-56.67M |
EPS (Diluted) | $-0.58 | $-6.88 | $-8.96 | $-12.14 |
Total Assets | $19.97M | $41.27M | $77.28M | $108.85M |
Total Liabilities | $14.50M | $47.26M | $57.61M | $62.30M |
Cash & Equivalents | $5.06M | $20.00M | $26.68M | $19.66M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-38.43M | $-54.75M |
Shares Outstanding | 12.93M | 8.49M | 5.89M | 4.83M |